115 related articles for article (PubMed ID: 32563544)
1. Pretreatment serum C-reactive protein is a significant prognostic factor in patients with soft tissue metastases.
Ishibashi Y; Kobayashi H; Sawada R; Okuma T; Okajima K; Zhang L; Hirai T; Ohki T; Ikegami M; Shinoda Y; Akiyama T; Goto T; Tanaka S
J Orthop Sci; 2021 May; 26(3):478-482. PubMed ID: 32563544
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Factors for Predicting Survival in Soft-tissue Sarcoma with Metastatic Disease at Initial Presentation.
Nakamura T; Katagiri H; Shido Y; Hamada S; Yamada K; Nagano A; Yamada S; Tsukushi S; Ishimura D; Matsumine A; Sudo A; Nishida Y
Anticancer Res; 2017 Jun; 37(6):3137-3141. PubMed ID: 28551655
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma.
Nakamura T; Matsumine A; Matsubara T; Asanuma K; Uchida A; Sudo A
Cancer; 2012 Feb; 118(4):1055-61. PubMed ID: 21761398
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy: An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).
Lindner LH; Litière S; Sleijfer S; Benson C; Italiano A; Kasper B; Messiou C; Gelderblom H; Wardelmann E; Le Cesne A; Blay JY; Marreaud S; Hindi N; Desar IME; Gronchi A; van der Graaf WTA
Int J Cancer; 2018 Jun; 142(12):2610-2620. PubMed ID: 29383713
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors affecting survival in metastatic soft tissue sarcoma: an analysis of 110 patients.
Iqbal N; Shukla NK; Deo SV; Agarwala S; Sharma DN; Sharma MC; Bakhshi S
Clin Transl Oncol; 2016 Mar; 18(3):310-6. PubMed ID: 26243399
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and impact of surgery in patients with metastatic soft tissue sarcoma at diagnosis: A population-based cohort study.
Zhang L; Akiyama T; Fukushima T; Iwata S; Tsuda Y; Takeshita K; Kawai A; Tanaka S; Kobayashi H
Jpn J Clin Oncol; 2021 May; 51(6):918-926. PubMed ID: 33774673
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the doubling time of serum C-reactive protein and alkaline phosphatase levels in primary bone and soft tissue tumors.
Yudoh K; Matsui H; Kamanori M; Ohmori K; Yasuda T; Tsuji H; Tatezaki S
Jpn J Cancer Res; 1996 Dec; 87(12):1288-95. PubMed ID: 9045965
[TBL] [Abstract][Full Text] [Related]
8. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
[TBL] [Abstract][Full Text] [Related]
9. Infiltrative tumor growth patterns on magnetic resonance imaging associated with systemic inflammation and oncological outcome in patients with high-grade soft-tissue sarcoma.
Nakamura T; Matsumine A; Matsubara T; Asanuma K; Yada Y; Hagi T; Sudo A
PLoS One; 2017; 12(7):e0181787. PubMed ID: 28727824
[TBL] [Abstract][Full Text] [Related]
10. The role of C-reactive protein in predicting post-metastatic survival of patients with metastatic bone and soft tissue sarcoma.
Nakamura T; Matsumine A; Asanuma K; Matsubara T; Sudo A
Tumour Biol; 2015 Sep; 36(10):7515-20. PubMed ID: 25913621
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival.
Billingsley KG; Burt ME; Jara E; Ginsberg RJ; Woodruff JM; Leung DH; Brennan MF
Ann Surg; 1999 May; 229(5):602-10; discussion 610-2. PubMed ID: 10235518
[TBL] [Abstract][Full Text] [Related]
12. Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma.
Que Y; Qiu H; Li Y; Chen Y; Xiao W; Zhou Z; Zhang X
BMC Cancer; 2015 Oct; 15():648. PubMed ID: 26432433
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes and prognostic factors of pulmonary metastasectomy for osteosarcoma and soft tissue sarcoma.
Yamamoto Y; Kanzaki R; Kanou T; Ose N; Funaki S; Shintani Y; Minami M; Outani H; Takenaka S; Hamada K; Yoshikawa H; Okumura M
Int J Clin Oncol; 2019 Jul; 24(7):863-870. PubMed ID: 30806840
[TBL] [Abstract][Full Text] [Related]
15. Repeat resection of pulmonary metastases in patients with soft-tissue sarcoma.
Weiser MR; Downey RJ; Leung DH; Brennan MF
J Am Coll Surg; 2000 Aug; 191(2):184-90; discussion 190-1. PubMed ID: 10945362
[TBL] [Abstract][Full Text] [Related]
16. The Diagnostic and Prognostic Value of Hematological and Chemical Abnormalities in Soft Tissue Sarcoma: A Comparative Study in Patients with Benign and Malignant Soft Tissue Tumors.
Ariizumi T; Kawashima H; Ogose A; Sasaki T; Hotta T; Hatano H; Morita T; Endo N
Ann Clin Lab Sci; 2018 Jan; 48(1):11-17. PubMed ID: 29530991
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein (CRP) as a prognostic factor for colorectal cancer after surgical resection of pulmonary metastases.
Li C; Xu Q; Chen L; Luo C; Ying J; Liu J
Bull Cancer; 2017 Mar; 104(3):232-236. PubMed ID: 28063672
[TBL] [Abstract][Full Text] [Related]
18. Risk stratification of patients undergoing pulmonary metastasectomy for soft tissue and bone sarcomas.
Lin AY; Kotova S; Yanagawa J; Elbuluk O; Wang G; Kar N; Elashoff D; Grogan T; Cameron RB; Singh A; Chmielowski B; Federman N; Nelson SD; Lee P; Eilber FC; Lee JM
J Thorac Cardiovasc Surg; 2015 Jan; 149(1):85-92. PubMed ID: 25312228
[TBL] [Abstract][Full Text] [Related]
19. Prognostic influence of the treatment approach for pulmonary metastasis in patients with soft tissue sarcoma.
Kawamoto T; Hara H; Morishita M; Fukase N; Kawakami Y; Takemori T; Fujiwara S; Kitayama K; Yahiro S; Miyamoto T; Fujimoto T; Fujita I; Kakutani K; Matsumoto T; Matsushita T; Niikura T; Kuroda R; Akisue T
Clin Exp Metastasis; 2020 Aug; 37(4):509-517. PubMed ID: 32436018
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary metastasectomy for osteogenic and soft tissue sarcoma: who really benefits from surgical treatment?
Mizuno T; Taniguchi T; Ishikawa Y; Kawaguchi K; Fukui T; Ishiguro F; Nakamura S; Yokoi K
Eur J Cardiothorac Surg; 2013 Apr; 43(4):795-9. PubMed ID: 22833540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
